Search

everythinglearnresearchcommunity

for

Search:↓

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

Atopic dermatitis shows a link between skin layers in inflammation, detectable with detailed gene analysis.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Targeting Vδ1+T-cells may help treat alopecia areata.

NK cells play a role in skin diseases like eczema and psoriasis.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

ILC1-like cells can cause alopecia areata by themselves.

Hair follicles regulate immune cells in the skin, and disrupting certain pathways can lead to skin issues and infections.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

The document suggests there might be a link between Kawasaki Disease and Alopecia Areata that needs more research.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.